62 results about "Adhesive proteins" patented technology

The invention relates to the technical field of repair compositions, and discloses a repair composition based on mussel mucin and application of the repair composition in skin barrier repair. The invention discloses a mussel mucoprotein-zinc composite microcapsule repair agent, which is prepared from the following components in parts by weight: mussel mucoprotein-zinc composite microcapsules, modified carboxymethyl chitosan, isolactone palmitate, a pH response type ceramide slow release system, dimeticone, cetostearyl alcohol, a calcium ion activating agent, an auxiliary repair factor, beheneth-25, caprylic / capric triglyceride, glyceryl monostearate, glyceryl distearate, pentanediol and citric acid. The preparation method comprises the following steps: adding ethanol, phenoxyethanol / ethylhexylglycerin, trehalose, beta-glucan and purified water; according to the whole technical scheme, through functional complementation and process optimization of all the components, synergistic interaction is achieved, the transpedermis water loss amount can be rapidly reduced, the water content of the skin cuticle is increased, the damaged skin barrier structure can be repaired from the source, and the resistance and stability of the skin are remarkably improved.

The application discloses a preparation method of high-purity recombinant mussel adhesive protein and belongs to the technical field of recombinant protein preparation. The amino acid sequence of Mfp-3 of Mytilus coruscus and the partial peptide segment of the amino acid sequence of preCol-D of Mytilus edulis are fused and expressed according to the idea of improving target protein expression by using fusion protein, and the improvement of the induction, tyrosinase modification and separation and purification process is combined to obtain the recombinant mussel adhesive protein with high purity, low endotoxin content and good adhesion performance. The successful preparation of the recombinant mussel adhesive protein provides a new idea for the industrial production of the recombinant mussel adhesive protein, provides raw material support for the multi-field application of the recombinant mussel adhesive protein, realizes the preparation of the customized sequence recombinant mussel adhesive protein according to application requirements, and promotes the application of the mussel adhesive protein in different fields.

The application provides a mussel mucin synthesis method and relates to the technical field of genetic engineering.The application improves the yield of mussel mucin by carrying out deletion mutation on the N-terminal sequence of the secondary structure of the mussel mucin amino acid sequence such as SEQ ID NO.1.The yield of mussel mucin in the prior art is about 2.57g / L, while the yield of mussel mucin in the application is about 5g / L, which is greatly improved compared with the yield of mussel mucin in the prior art.On this basis, the mussel mucin is modified by dopa through co-expression of tyrosinase, and the expression amount of the tyrosinase is controlled through different intensities of RBS, so as to regulate the modification degree of dopa, improve the yield of mussel mucin, and realize controllable modification of dopa in the mussel mucin, finally obtaining mussel mucin with high yield and different modification degrees of dopa.

The invention discloses oral multi-effect analgesic and anti-inflammatory gel and a preparation method thereof, and belongs to the technical field of medical gel. The gel is prepared from mussel mucin grafted hydroxypropyl chitosan, a poly (N-isopropylacrylamide)-co-acrylic acid copolymer, quercetin-zinc coordination nanoparticles, a local anesthetic compound wrapped by temperature-sensitive lipidosome, a gamma-polyglutamic acid-catechin gel matrix, aloe polysaccharide, dipotassium glycyrrhizinate, and sodium hyaluronate and potassium sorbate which can be selectively added, wherein the local anesthetic compound is prepared from the mussel mucin grafted hydroxypropyl chitosan, the poly (N-isopropylacrylamide)-co-acrylic acid copolymer, the quercetin-zinc coordination nanoparticles, the temperature-sensitive lipidosome, the gamma-polyglutamic acid-catechin gel matrix, the aloe polysaccharide and the dipotassium glycyrrhizinate. During preparation, part of the components and water are stirred to obtain a mixed solution, and then the other components are added and stirred into gel. According to the gel, the leakage rate of local anesthetics is reduced by stabilizing the liposome through the zinc ions, the quercetin adjusts the phase transition temperature of the liposome to realize preferential drug release at the pain part, the mussel mucin and the copolymer form a reversible hydrogen bond network to enhance the mucous membrane adhesive force, and the inflammatory environment triggers the gel permeation drug release, so that the gel has the advantages of multiple-effect synergy, strong adhesion and the like; the problems that existing oral gel is short in analgesia time and insufficient in anti-inflammation can be effectively solved.

The invention discloses a special membrane material for targeted trapping of macrobrachium larvae in water and a preparation method of the special membrane material, and belongs to the field of water environment biological pollution prevention and control. The membrane material is of a multi-layer composite structure and comprises a nanofiber membrane base material layer, an interface adhesion layer and a functional modification layer. The interface adhesion layer is bionic coacervate gel formed by curing hydrophobic polyelectrolyte and phytic acid; the functional modification layer is covalently grafted with a bionic adhesion protein active peptide fragment and a macrobrachium larva chemical pheromone. The material actively attracts larvae to approach through chemical pheromones, high-strength adhesion capture is achieved through bionic peptide fragments rich in aromatic and cationic amino acids, and trapping is integrated. The preparation method comprises the steps of electrostatic spinning of a base material, surface activation, gel coating, functional modification and the like. The material disclosed by the invention has high selectivity and high capture rate on the larvae of the Limnoperna fortunei, is environment-friendly, long-acting and stable, and is suitable for green prevention and treatment of fouling of the larvae of the Limnoperna fortunei in facilities such as water pipelines and pump stations.

The present disclosure describes PLPC-DB, an ultrapure phospholipoproteomic composition consisting of essential phospholipids, bioactive proteins, and intercellular regulatory factors, derived from the supernatant of peripheral blood mononuclear cells (PBMCs). This composition achieves a purity level exceeding 99% through a patented purification process that integrates high-speed advanced centrifugation and selective ultrafiltration, ensuring the structural stability and functional integrity of its bioactive components. PLPC-DB is optimized for advanced research and diagnostic applications, providing reproducibility, consistency, and safety across multicenter studies. The essential biomolecular components of PLPC-DB include phosphatidylcholine and phosphatidylserine, which contribute to membrane stability and intracellular signaling, while cell communication peptides enhance intercellular signaling, homeostatic regulation, and biochemical coordination. Structural and regulatory lipids support cell membrane biogenesis and functional stability, whereas adhesion and signaling proteins mediate cell-cell interactions and immune response coordination. Additionally, bioactive regulatory factors modulate immune and inflammatory responses, contributing to tissue regeneration and metabolic homeostasis.

The invention relates to the technical field of medical biological materials, and discloses a mussel mucin-chondroitin sulfate composite hydrogel and a preparation method and application thereof, and the preparation method comprises the following steps: respectively preparing a mussel mucin aqueous solution and a chondroitin sulfate aqueous solution; the mass volume concentration of the mussel mucoprotein aqueous solution is 1%-10%, the mass volume concentration of the chondroitin sulfate aqueous solution is 1%-10%, the mass ratio of the mussel mucoprotein to the chondroitin sulfate is 3: 1-1: 3, the two solutions are mixed and stirred or oscillated under the conditions that the temperature is 4-37 DEG C and the pH value is 7.0-9.0, a cross-linking reaction is conducted, and hydrogel is formed; the cross-linking mode is physical cross-linking, chemical cross-linking or physical-chemical dual cross-linking; according to the invention, excellent tissue adhesion, injectability, self-healing property and biodegradability are realized, cell adhesion and proliferation can be effectively promoted, and the gel is suitable for various medical beauty scenes such as skin filling, wound repairing and anti-aging nursing.

The application discloses a Mycoplasma bovum adhesion protein FtsZ and application thereof. The nucleic acid sequence of the Mycoplasma bovum adhesion protein FtsZ is shown as SEQ ID NO. 1. The application also discloses a recombinant plasmid pET-30a-ftsZ and an E. coli containing the recombinant plasmid pET-30a-ftsZ. ftsZ The recombinant protein rFtsZ has the advantages of being capable of specifically combining with EBL cell membrane protein, being capable of combining with extracellular matrix components (fibronectin, fibronectin, laminin and type IV collagen), having the direct adhesion host cell effect, having good antigenicity, being capable of producing high-level antibodies, being capable of providing good immune protection effect, and providing a new target and thought for elucidating the pathogenic mechanism of the Mycoplasma bovum and developing a new vaccine and medicine.

The invention belongs to the technical field of medical dressings, and particularly relates to a gel dressing for relieving postoperative lymphedema of breast cancer and a preparation method thereof.The gel dressing is prepared from, by weight, 0.1-0.5 part of active medicine, 8-12 parts of modified matrix, 0.2-0.8 part of dopamine hydrochloride, 2 parts of dispersing agent and 0.5-1.5 parts of enhancer, menthol with functions of promoting infiltration and inducing diuresis to alleviate edema is used for modifying mussel mucoprotein with good biocompatibility, the crosslinking gelling property of the mussel mucoprotein is improved, meanwhile, along with hydrolysis breakage of covalent bonds, gel slowly collapses to release active drugs, and the active drugs and the menthol cooperate with each other, and the postoperative lymphedema of breast cancer is treated from various mechanism ways.

The invention discloses a method for producing recombinant I-type mussel mucin rich in dopa, and belongs to the technical field of genetic engineering. According to the invention, Ala-Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys decapeptide of a natural type I mussel mucin sequence is taken as a repetitive unit, a gene expression vector for tandem expression of peptide fragments with different repetitive numbers is constructed, and pichia pastoris host bacteria are transformed, so that type I mussel mucin precursors with different molecular weights are obtained; in vitro, a precursor is subjected to dopa modification by high-activity tyrosinase obtained through screening in a mixed system containing ascorbic acid ethyl ether, copper sulfate and the like, and the recombinant I-type mussel mucin rich in dopa groups is obtained after purification. The recombinant I-type mussel mucin rich in dopa obtained by the invention has the advantages of high purity and high dopa modification rate, and has wide application prospects in the fields of biomedicine, surface chemistry and the like.

The present application relates to a kind of mussel-based composite coacervate based on mussel adhesive protein and its preparation method and purposes, the mussel-based composite coacervate includes mussel adhesive protein and anionic polyelectrolyte material;The mass ratio of mussel adhesive protein and anionic polyelectrolyte material is (0.05~4):1;The oxidation rate of dopa residue in the mussel adhesive protein in the composite coacervate is 0.1%~70.0%.The present application realizes the accurate control of the preparation of the composite coacervate formed by regulating the concentration, mass ratio and system pH of mussel adhesive protein and anionic polyelectrolyte material, and then improves its performance and effect as tissue adhesive, wound repair dressing, acute hemostatic material, local drug delivery carrier and drug release system field or bone tissue repair, cartilage repair and tissue filling and support field.

This invention discloses a recombinant mussel adhesive protein, its preparation method, and its applications. The recombinant mussel adhesive protein includes a mussel adhesive protein tag, the amino acid sequence of which is shown in SEQ ID NO.2. The recombinant mussel adhesive protein is obtained by recombinantly fusing the aforementioned mussel adhesive protein tag with mussel adhesive protein, followed by in vitro hydroxylation modification. This recombinant mussel adhesive protein exhibits advantages such as high expression level, high purity, high Dopa content, high adhesion, and promotion of various cell growth mechanisms. It can be used in the preparation of adhesives or in the preparation of formulations that promote cell growth.

1. The name of the design product: packaging box (multiple-factor medical mussel mucin liquid dressing). 2. The use of the design product: for packaging box. 3. The design points of the design product: in the combination of shape and pattern. 4. The picture or photo that best indicates the design points: perspective view.

A process (1) for producing an article (2) from a plant-based material (3) includes providing (4) genetically modified microorganisms (5) in which the genetic modification (12) results in overexpression of at least one adhesive protein (6); mixing (7), preferably blending, of the plant-based material (3) with the genetically modified microorganisms (5), which are preferably held in a culture medium (11), to obtain a mixture (8); expressing of the adhesive protein (6); and hardening (10) of the mixture (8).

An antiviral coating composition is provided. An antiviral coating composition according to one embodiment of the present invention is implemented by including an antiviral component comprising an antiviral fusion protein in which an antiviral motif is bound to an adhesive protein. According to the present invention, the composition has excellent processability enabling easy provision on various surfaces of various products, has adhesion sustainability enabling an adhesive state to be maintained for a long period of time after being adhered to a surface, and has activity sustainability enabling antiviral activity to be maintained for a long period of time without a loss in activity according to external conditions during preparation, storage and use.

This invention relates to recombinant mussel adhesive proteins, the nucleic acid molecules encoding them, nucleic acid constructs, expression vectors, recombinant engineered strains, pharmaceutical compositions, preparation methods, purification methods, and applications. This invention assembles and splices partial functional sequences from different mussels and type III collagen to obtain several novel mussel adhesive protein sequences. Further screening yielded recombinant mussel adhesive proteins Mfp5, Mfp55, Mfp131, and Mfp151, suitable for large-scale industrial production and exhibiting high expression levels. Efficacy experiments demonstrated that these proteins significantly promote cell migration, indicating their excellent cell repair function and broad application prospects.

The application discloses a method for constructing a model for recognizing mussel adhesive proteins, and belongs to the technical field of bioinformatics, and specifically comprises the following steps: inputting an amino acid sequence of a target protein, obtaining standard electromagnetic response waveforms of each amino acid residue in a variety of non-aqueous solvent environments, and sorting to form an initial electromagnetic fingerprint; polypeptide fragment fingerprints are generated through sliding window cutting, shared frequency components of each fragment waveform are extracted, and characteristic sequences are formed by sorting according to intensity; local patterns and context dependencies of the sequences are extracted through an encoder network, and a context vector is output; a decoder network maps the vector into a fixed-dimension embedding representation; known protein sequences with or without adhesive functions are used as training samples, the above-mentioned processing is performed on each sample to obtain a set of embedding representations, a binary classification model is trained, and a recognition model is obtained. The application realizes function recognition by using electromagnetic response characteristics of proteins in non-aqueous environments.

1. Name of the designed product: packing box (mussel adhesive protein anorectal dressing). 2. Use of the designed product: for packing products. 3. Design points of the designed product: in the combination of shape and pattern. 4. Picture or photo best indicating the design points: front view.

The invention provides a layered graphene / epoxy resin composite coating and a preparation method thereof. The preparation method comprises the following steps: pretreating the surface of mussel mucoprotein (MAP), and alternately and repeatedly preparing an EP film and a graphene layer by adopting EP film spin-coating and graphene self-assembly based on a Marangoni method to obtain a Lay-GEC coating. According to the layered graphene / epoxy resin composite coating and the preparation method, self-assembly and horizontal directional arrangement of the graphene nanosheets on the water surface are achieved through the Marangoni effect, and the compactness and barrier performance of the coating are improved. And the catechol group of the mussel protein is utilized to realize the spontaneous coordination repair of the scratched part, so that the self-repair capability and durability of the coating are improved.

The construction method comprises the following steps: amplifying a Cwp8 protein gene on a clostridium difficile genome, constructing the Cwp8 protein gene on a pLEB124 plasmid to obtain a recombinant plasmid pLEB124-Cwp8, and transferring the recombinant plasmid pLEB124-Cwp8 into lactococcus lactis F44 to obtain the clostridium difficile resistant lactococcus lactis, which is named as Lla-Cwp8, and the clostridium difficile resistant lactococcus lactis is named as Lla-Cwp8, and the clostridium difficile resistant lactococcus lactis is named as Lla-Cwp8. The surface of the Lla-Cwp8 disclosed by the invention can express the adhesion protein and realize high yield of Nisin. Experiments prove that Lla-Cwp8 has strong competition, rejection and translocation capabilities on clostridium difficile in vitro, can effectively reduce the survival rate of clostridium difficile and reduce colon shortening in vivo, can significantly reduce the expression of virulence proteins TcdA and TcdB and the expression of immune factors TNF-alpha and IL-6, and has a treatment effect on clostridium difficile infection.

The invention relates to a recombinant mussel mucin MFP535. The invention further provides a coding nucleic acid, a recombinant vector, a recombinant strain and the like for highly expressing the MFP535, so that the efficient expression of the recombinant mussel mucin MFP535 is realized. The invention further provides a purification and separation method for the recombinant mussel mucin MFP535, the purity of the MFP535 finally obtained through purification reaches 96% or above, the tyrosine oxidation rate reaches 0.44%, and the endotoxin is lt; 1 EU / mg. The recombinant mussel mucin MFP535 has an obvious effect of promoting cell growth. The separation and purification method disclosed by the invention is high in specificity, mild in operation condition, simple in step, good in purification effect, high in recovery rate, low in cost, high in speed and beneficial to expanded production.

The application discloses a NEED short peptide modified polylactic acid implant material and a preparation method and application thereof, and relates to the technical field of biomedical materials. The preparation method of the NEED short peptide modified polylactic acid implant material provided by the application is as follows: an interface composed of polylactic acid material is constructed on the surface of an implant material substrate, the interface is activated, and the NEED short peptide is fixed on the interface. The polylactic acid implant material prepared by the application utilizes the interface composed of the polylactic acid material and the NEED short peptide with negative electricity to enhance the adhesion stability of adhesion proteins such as fibronectin and to enhance the subsequent cell adhesion response, thereby promoting cell adhesion and implant material integration. The material can be widely applied to the fields of degradable vascular stents, bone repair materials, dental implants, tissue engineering stents and nanofiber membranes, and can also provide a new technical scheme for interface functionalization of implant materials in a metabolic abnormal environment, and has a wide application prospect.

This invention provides a method for preparing a thermosensitive gel for the prevention and treatment of nasal diseases and its application. By weight and volume percentage, it comprises recombinant human type III collagen, mussel adhesive protein, an anti-allergy agent, traditional Chinese medicine extracts, thermosensitive materials, and a sodium pyruvate-cocamidopropyl betaine ion-pair complex. This invention, by pre-forming the ion-pair complex, simultaneously solves the technical problems of existing nasal gels, such as poor anti-dilution ability, short adhesion time, and easy inactivation of active ingredients. The product is liquid below 30°C and can be sprayed for complete nasal coverage. At body temperature, it transforms into a gel within 2 minutes for long-lasting adhesion, exhibiting rapid anti-inflammatory, nasal patency-clearing, antipruritic, and mucosal repair effects. It is suitable for the prevention and treatment of allergic rhinitis and sinusitis, as well as nasal wound care, with significantly better efficacy than similar commercially available products.

The application discloses a kind of polypeptide, underwater adhesive, adhesive coating and its preparation method and application, the amino acid sequence of the polypeptide is Lys-DOPA-Phe-Lys-DOPA-Phe.The underwater adhesive prepared by the polypeptide of the application and the adhesive coating formed have considerable underwater adhesion, and have certain resistance to acidic environment and salt environment.In addition, since the polypeptide only contains 6 natural amino acids, compared with natural marine biological adhesive protein containing dozens of hundreds of amino acids, the polypeptide and underwater adhesive of the application have simple sequence, simple and economical synthesis.

1. The name of the design product: packaging box (medical imitation mussel adhesive protein high polymer anorectal gel). 2. The use of the design product: for packaging bag. 3. The design points of the design product: the combination of shape and pattern. 4. The picture or photo that best indicates the design points: front view.

The invention discloses a mytilus coruscus byssus adhesion protein mutant, application thereof and a method for identifying phenotypic characters of mytilus coruscus byssus, and relates to the technical field of biology. The amino acid sequence of the mytilus coruscus byssus adhesion protein mutant is as shown in SEQ ID NO. 4. In-depth study shows that non-synonymous mutation of a mytilus coruscus Mfp3-6 gene coding region can directly influence functional characteristics of protein, so that a clear causal relationship is established between a genotype and a mytilus coruscus byssus adhesion performance phenotype. The invention further provides a mytilus coruscus byssus adhesion protein mutant. The mytilus coruscus byssus adhesion protein mutant has an excellent adhesion strength characteristic, so that the mytilus coruscus byssus adhesion protein mutant has a wide application prospect in the field of functional adhesion materials. The protein mutant can be widely applied to development of materials such as medical glue, dressing and gel, provides important technical support for research and development of bionic adhesion technology and novel biological materials, and has good industrialization potential and social value.

The invention relates to an engineering probiotic oral nano capsule modified by a nano material as well as a preparation method and application of the engineering probiotic oral nano capsule. The engineering modification of probiotics comprises the steps of knocking out a clbA gene and overexpressing an Sj16 protein and a GbpA protein. The intestinal adhesion protein GbpA is expressed on the surface of the engineered escherichia coli, an ultrasonic response element is integrated, the immunomodulatory protein Sj16 can be controllably expressed under ultrasonic stimulation, the adhesion and colonization capacity of the engineered escherichia coli in the intestinal tract is enhanced through engineered modification, the immune balance of the intestinal mucosa is cooperatively regulated, and the immunomodulatory effect of the engineered escherichia coli is improved. The generation and secretion of pathogenic autoantibodies from intestinal tracts are obviously reduced. On the basis, the molybdenum-based monatomic nano-material is functionally modified by using an enteric polymer, and a uniform nano-material-polymer composite coating is formed on the modified probiotics by adopting an in-situ wrapping technology, so that the nano-material-polymer composite coating shows a remarkable effect in the aspect of treating the autoimmune nephritis and has an important clinical application value.

The present disclosure describes PLPC-DB, an ultrapure phospholipoproteomic composition consisting of essential phospholipids, bioactive proteins, and intercellular regulatory factors, derived from the supernatant of peripheral blood mononuclear cells (PBMCs). This composition achieves a purity level exceeding 99% through a patented purification process that integrates high-speed advanced centrifugation and selective ultrafiltration, ensuring the structural stability and functional integrity of its bioactive components. PLPC-DB is optimized for advanced research and diagnostic applications, providing reproducibility, consistency, and safety across multicenter studies. The essential biomolecular components of PLPC-DB include phosphatidylcholine and phosphatidylserine, which contribute to membrane stability and intracellular signaling, while cell communication peptides enhance intercellular signaling, homeostatic regulation, and biochemical coordination. Structural and regulatory lipids support cell membrane biogenesis and functional stability, whereas adhesion and signaling proteins mediate cell-cell interactions and immune response coordination. Additionally, bioactive regulatory factors modulate immune and inflammatory responses, contributing to tissue regeneration and metabolic homeostasis.

There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutically acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and / or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

1. Name of the product in this design: Packaging Box (Recombinant Mussel Adhesive Protein Medical Dressing). 2. Purpose of this design: Packaging box for medical dressings. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model. 5. The right view is the same as the left view, so the right view is omitted.